Extensive Iliocaval Deep Vein Thrombosis Provoked by Coronavirus Disease 2019 (COVID-19) in the Setting of an Inferior Vena Cava Filter

Anisa Raidah; Nolberto Jaramillo Jr; Katherine F Pradas; Anantha Ramanathan

doi:10.7759/cureus.51873

Extensive Iliocaval Deep Vein Thrombosis Provoked by Coronavirus Disease 2019 (COVID-19) in the Setting of an Inferior Vena Cava Filter

Cureus. 2024 Jan 8;16(1):e51873. doi: 10.7759/cureus.51873. eCollection 2024 Jan.

Authors

Anisa Raidah^{1

2}, Nolberto Jaramillo Jr^{1

2}, Katherine F Pradas³, Anantha Ramanathan²

Affiliations

¹ Surgery, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, USA.
² Surgery, Nassau University Medical Center, East Meadow, USA.
³ Surgery, Stony Brook University, Stony Brook, USA.

Abstract

Thrombotic events are well-known complications of coronavirus disease 2019 (COVID-19). Inferior vena cava filters (IVCF) are devices used to prevent pulmonary embolism (PE) and also increase the risk of thrombotic complications. Here, we describe the case of a 38-year-old female with extensive bilateral lower extremity deep vein thrombosis (DVT) and thrombosis of the infrarenal inferior vena cava (IVC) in the setting of an IVCF and symptomatic COVID-19. The IVCF had been placed a few months prior for a left femoral DVT and PE after spinal surgery. This patient was treated with pharmacomechanical thrombectomy and ultrasound-assisted thrombolysis followed by angioplasty and anticoagulation. The IVCF was retrieved after confirming there was no residual DVT when the patient recovered from COVID-19 infection. This case of a rare combination of IVCF-related thrombosis secondary to COVID-19 highlights the potential pitfalls of IVCF in this situation.

Keywords: covid-19; deep vein thrombosis (dvt); inferior vena cava thrombosis; ivc filter complication; sars-cov-2.

Publication types

Case Reports